Local attitudes in the treatment of low prognosis head and neck squamous cell carcinoma by Borg Xuereb, Herman Karl et al.
JJou 
 
 
 
Journal Article 
 
 
Malta Medical Journal    Volume 27 Issue 02 2015                                                                                                                
 
 
Abstract 
The incidence of head and neck carcinoma in Malta 
is 2.44 per 100,000 population, with 5-year survival rate 
of 20%.  International studies have however shown that 
head and neck squamous cell carcinoma (HNSCC) 
carries an average 30% survival rate.  The cost of 
treatment of low prognosis HNSCC patients in Malta is 
roughly €62,500 per year per person and considering 
that 7 patients out of those diagnosed are treated 
curatively annually, the total cost would increase to 
nearly half a million Euros per annum.  In view of this, 
one is bound to ask the question whether not treating 
patients with a 30% survival rate is justifiable, especially 
in view that surgical and oncologic treatment can result 
in severe disfigurement and poses great physical and 
psychological stress on patients.  No studies about local 
decision-making with respect to HNSCC have been 
published.  This study set out to explore this issue from 
the ethical point of view, taking into account a number 
of variables with respect to treatment and the patient 
factors.  A pre-determined set of questions was 
formulated and these questions were tackled by ten 
medical professionals, nine of which had direct contact 
with HNSCC patients.  Issues such as informed consent, 
old age, quality of life, social variables, autonomy, 
healthcare rationing, medico-legal problems and past 
experiences with patients have been identified and 
discussed with reference to the local situation.  It was 
noted that the majority of interviewed professionals 
(70%), still emphasised the need to provide full 
treatment for low prognosis HNSCC. 
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Introduction 
Head and neck malignancy is the sixth most 
common cancer in the world.  Head and neck squamous 
cell carcinoma (HNSCC) is the most frequently 
encountered type.  The incidence of head and neck 
carcinoma in Malta is 2.44 per 100,000 population with 
5-year survival rate of 20%,1 although several studies 
have shown that HNSCC generally carries a 30% 
survival rate.2-4 The TNM staging method is used by 
many clinicians to determine the aggressiveness and 
severity of cancer, on which a treatment plan can be 
devised from established protocols.  However, the 
Western world tends to be more legally and 
scientifically oriented and often finds difficulty in taking 
ethical moral decisions in such cases.5 
Although decisions with respect to head and neck 
cancer are not very different from the ones taken for 
other cancers, a differentiating feature is that head and 
neck cancers tend to present late and they would entail 
radical surgery with subsequent disfigurement and 
dysfunction which significantly impinge on the quality 
of life of the sufferer.  Several factors need to be 
considered when it comes to decision making, including 
informed consent, counselling, treatment withdrawal, 
end-of life issues as well as the patient’s personality, 
social, cultural and family background.  
Health care in Malta is limited by its budget.  This 
leads to prioritization and rationing in health care, 
whether this being implicit or explicit.6 One also has to 
keep in mind the direct (medications, services, therapies, 
tests, etc.), indirect (productivity, disability, etc.) and 
intangible (often psychosocial) costs of health.7  Based 
on breakdown cost calculations, if one considers all 
medical personnel involved in the care of HNSCC 
patients and adds up routine costs of procedures, hospital 
stay and follow up, a conservative estimate for treating a 
single HNSCC patient in one year would be around 
62,500 Euros. 
Social justice including the fair distribution of 
health care resources is possibly the most important 
issue in bioethics.8 Access to health care across borders, 
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poverty, age and ethnicity are all important to consider 
when planning health care distribution.  Fortunately, 
poverty is not much of an issue for Malta since everyone 
is entitled to free health care, irrespective of his social 
status.  Age discrimination can be a problem as seen in 
the Britain, where age is given importance with respect 
to treatment provision.9 In recent years, Malta has seen a 
significant influx of irregular immigrants which posed a 
new challenge for our country.  Other minority groups 
such as the homeless face similar problems in that they 
tend to get marginalised by the people with consequent 
social, political and possibly health detriments.10 
Two models of care representing the two extremes 
of modern day medical practice can influence decision-
making, management and the doctor-patient relationship. 
These are ‘evidence-based medicine’ and ‘patient-
centred medicine’.  Evidence-based medicine integrates 
the best clinical knowledge of a medical practitioner 
acquired through experience and clinical practice with 
current evidence-based medicine in the care of 
individual patients.11 This approach tends to disregard 
the individuality, emotions and preferences of patients in 
the decision-making process.12  Patient-centred care 
takes into consideration the patient as a person with his 
or her individual ideas, emotions and expectations, and 
merges these aspects with a common goal in terms of 
care, health promotion and enhancement of the doctor-
patient relationship.13 
 
Methodology 
When compared to other countries, the number 
of medical professionals involved in the management of 
HNSCC in Malta is small.  In this study, a set of 
qualitative face-to-face video-recorded semi-structured 
interviews were created.  In these interviews, the 
interviewee had to identify himself before being asked a 
set of 14 open-ended questions in sequence (Table 1).  
Both Maltese and English versions were available.  The 
subjective and elaborated responses were then recorded 
digitally on a laptop computer.  These were later 
transcribed and the data analysed. 
The interviewees were all hospital-based 
professionals, and all the interviews were conducted on 
hospital grounds.  Each was provided with three 
documents.  The first served as a general introduction to 
the study, the second was a consent form and the third 
consisted of the questions to be asked.  All interview 
recordings were deleted once the replies were analysed. 
 
 
 
Table 1: Questions asked during each interview 
Interview questions 
A 
Do you think the subject has been explained 
adequately to you? 
B Do you think it is relevant to the local setting? 
C How often do you see such cases per year? 
D 
Do you think it is ethical to withhold treatment for 
low prognosis Head and Neck cancer patients and 
only offer palliative treatment? 
E Yes/no: on what grounds? 
F 
In your experience is the amount of suffering 
incurred by the patient  during and after the 
treatment  justified? 
G 
Do you think that the expense incurred by treating 
these patients is justified where the same money 
may be used for other groups of patients with a 
better prognosis? 
H 
How expensive do you think the treatment of one 
patient might be? 
I 
God forbid, if you had to be in such a situation what 
type of treatment if any would you prefer?  
J 
Should you be involved in this decision making 
process? 
K 
Do you think you are involved in the decision 
making? 
L 
In your experience do you recall any specific 
patients in this prognosis group who unexpectedly 
fared really well or really badly? 
M 
Did these episodes affect your clinical decision 
making vis a vis the management of subsequent 
patients? 
N Any further comments? 
 
Results 
10 medical and para-medical staff (7 males and 
3 females) were interviewed, with a mean age of 43.7 
years (29-53 years).  Their respective professional 
backgrounds are displayed in Figure 1, and the mean 
professional working years was 20.6 years.  Each 
interview lasted a mean of 12 minutes.  Nine of the 
professionals interviewed had direct daily contact with 
HNSCC patients. 
Figure 2 shows the results of nine of the eleven 
questions that were asked.  
With respect to Question C, the mean incidence of 
HNSCC estimated by the respondents was 11.7 cases per 
year. 
When asked whether or not it would be ethical 
to withhold treatment for low prognosis Head and Neck 
cancer patients and only offer palliative treatment 
(Question D), which is central to this study, 3 agreed to 
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withhold treatment and 7 considered this decision 
unethical.  However, 7 respondents emphasised that 
informed consent should always take priority.  
 
Figure 1: Professions of interviewees (n=10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Responses to nine of the eleven questions 
asked in the interview. Answers to Questions C, E, H, I, 
J and N were more elaborate and the data could not be 
adequately presented graphically 
 
 
 
 
 
 
 
 
 
 
 
Regarding Question E, of those who would 
withhold treatment, one mentioned that although the 
patient should preferably take part in the decision-
making process, this may not be true in all cases.  For 
example when the patient has a low IQ or other co-
morbidities interfering with the treatment plan, the 
doctor may decide for the patient.  One also argued that 
patients would endure much suffering if administered 
the full treatment, so might as well opt for palliative care 
alone. 
Seven medical professionals emphasised the need 
to provide full treatment for low prognosis HNSCC.  
One based his reasoning that a prognosis of 30% is very 
much similar to other types of cancers which would 
normally still merit treatment. Two interviewees pointed 
out that the patient should be looked at and treated 
holistically and not only from the cancer point of view.  
Another interviewee stated that every patient is entitled 
to treatment because we do not know who will survive 
or not, and one should never consider the social value of 
the patient when it comes to deciding to opt for surgery 
or not.  Finally, the need to avoid providing the patient 
with falsely high expectations was brought up. 
When asked to elaborate further on their answer to 
Question E, a number of considerations were mentioned 
by the interviewees and are shown in Figure 3. 
 
Figure 3: Incidence of considerations as mentioned by 
interviewees when asked to elaborate on their answer to 
Question D 
 
 
 
 
 
 
 
 
 
 
 
 
 
When asked to estimate a price for a full 5-year 
treatment of a patient with HNSCC (Question H), a 
mean price of €37,222 was quoted (range €10,000-
€100,000). One interviewee could not estimate a price. 
Question I placed the clinical profession in the 
patient’s seat.  Three would accept the full treatment, 
two preferred palliative care, four were undecided and 
one preferred not to be treated.  Many argued that there 
were a lot of variables that needed to be considered, 
mainly age and social issues such as family. 
When asked to provide further comments, eight of 
the interviewees agreed that patients form an important 
part in the decision making process and that 
multidisciplinary teams (which are lacking locally) are 
of utmost importance in the holistic management of 
patients.  There was the need of standard paramedical 
protocols and audits aimed at assessing survival and 
quality of life.  Furthermore, the more experienced 
surgeons tend to favour conservative treatment. 
 
Discussion 
Question D was by far the most important, and on 
which this study is actually based.  The responses were 
essential for evaluation of the local decision-making 
process.  In some situations, informed consent requires 
care and skill to be extracted properly.  However, it is 
close to impossible to explain all the outcomes so that 
the patient can a make truly informed choice.  Being 
faced by a distraught patient does not help either.  
Sometimes doctors try to soften the blow by putting 
some details aside.  Furthermore, many times the 
relatives direct the physician on what to say, when and 
how to say it.14  This has been the norm for many years, 
whereby non-disclosure of sensitive information to the 
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patient regarding serious or terminal illness was 
considered taboo.15 On the other hand, safeguarding the 
right to autonomy is a prerequisite in showing respect 
for human integrity.16 Combining disclosure with 
autonomy requires good negotiation techniques, merging 
the physician’s medical knowledge with the cultural 
factors underlying the family’s and patient’s views. 17 
Physiological age was considered more important 
than old age by the majority of interviewees.  This is 
understandable as age-related physiological changes and 
co-morbidities expose the elderly to certain risks. For 
many elderly patients, it is the way they live their final 
years that matters most rather than by how many years 
they can prolong life.18  A multidisciplinary team may 
help to improve quality of life of such patients, which is 
very reasonable in this regard.  In addition, 
psychological interventions which target social support 
are important in diminishing treatment-related side-
effects.19  
Seeing how a small number of medical 
professionals are aware of so many ethical issues, one 
can identify an element of egalitarianism and 
utilitarianism as well.  Decisions are often based on a 
combination of morals, intuition and evidence-based 
medicine. Intuition in itself can be useful in some 
situations, but not so in others.20 Rationality and 
consistency may be challenged in the face of a decision 
harassed by variables such as worry, risk aversion and 
perception of danger.21 
Traditional healthcare ethics often call for a more 
paternalistic approach, which may conflict with the 
modern ethical principles of autonomy and transparency 
in decision-making.22  
Expensive interventions have forced doctors to 
shift their approach from the individual to the wider 
community.23 Health responsibility comprises both a 
personal and a social aspect. This led to the concept of 
co-responsibility, which indicates the subjects and 
objects of health responsibilities, and considers 
responsibility as being different from prioritization of 
treatment methods.24 
The element of solidarity in health care is 
strongly defended and is based on three factors. 
Emotional bonds should exist among interacting 
members of the group, which are united by universal 
goals and ideals. There must also be an element of 
sacrifice within the group. More recently, the criteria 
which define solidarity have been extended to include 
responsibility for health, communal health benefit, 
acknowledgement of utilitarian ideas which promote the 
common good and sacrificing one’s own care so that 
others may benefit.5  
 
Conclusion 
This paper was part of the first author's Master of 
Arts in Bioethics at the University of Malta. It portrays 
that the majority of professionals interviewed agree that 
it is unethical to withhold treatment for low prognosis 
HNSCC patients. However, not treating is by no means 
not caring. Indeed those who chose not to treat at the 
outset based their decision on a holistic view of the 
patient and the possible consequences of the actual 
treatment, which included more suffering and the risk of 
giving false hopes. Finally, the principles of the common 
good and justice ensured that fairness ruled over the 
distribution of health care resources.25 
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